Skip to content

Clinical trials

Prostatic Hyperplasia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: Poland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20051
20072
20091
20104
20162
20192
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Europe B.V.2
Eli Lilly and Company2
Urovant Sciences GmbH2
Allergan1
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
GlaxoSmithKline1
Jagiellonian University1
Medical University of Lodz1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia15
Lower Urinary Tract Symptoms4
Urinary Bladder, Overactive3
Carcinoma, Neuroendocrine1
Diabetes Insipidus1
Hyponatremia1
Neuroendocrine Tumors1
Prostatic Neoplasms1
Urinary Retention1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.